Global Antiepileptic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 146964
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Scope of the Report:

This report focuses on the Antiepileptic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures.

The worldwide market for Antiepileptic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

GlaxoSmithKline

Johnson & Johnson

Sanofi

Pfizer

Novartis

Abbott

Sunovion

Cephalon (Teva)

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

First generation

Second generation

Market Segment by Applications, can be divided into

Hosptial

Clinic

Research

There are 15 Chapters to deeply display the global Antiepileptic Drugs market.

Chapter 1, to describe Antiepileptic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antiepileptic Drugs, with sales, revenue, and price of Antiepileptic Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antiepileptic Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Antiepileptic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Antiepileptic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Antiepileptic Drugs Introduction

1.2 Market Analysis by Type

1.2.1 First generation

1.2.2 Second generation

1.3 Market Analysis by Applications

1.3.1 Hosptial

1.3.2 Clinic

1.3.3 Research

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 GlaxoSmithKline

2.1.1 Business Overview

2.1.2 Antiepileptic Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GlaxoSmithKline Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Johnson & Johnson

2.2.1 Business Overview

2.2.2 Antiepileptic Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Johnson & Johnson Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sanofi

2.3.1 Business Overview

2.3.2 Antiepileptic Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sanofi Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Pfizer

2.4.1 Business Overview

2.4.2 Antiepileptic Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Pfizer Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Antiepileptic Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Abbott

2.6.1 Business Overview

2.6.2 Antiepileptic Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Abbott Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Sunovion

2.7.1 Business Overview

2.7.2 Antiepileptic Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Sunovion Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Cephalon (Teva)

2.8.1 Business Overview

2.8.2 Antiepileptic Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Cephalon (Teva) Antiepileptic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Antiepileptic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Antiepileptic Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Antiepileptic Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Antiepileptic Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Antiepileptic Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Antiepileptic Drugs Market Analysis by Regions

4.1 Global Antiepileptic Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Antiepileptic Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Antiepileptic Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Antiepileptic Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Antiepileptic Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Antiepileptic Drugs Sales and Growth Rate (2013-2018)

4.5 South America Antiepileptic Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Antiepileptic Drugs Sales and Growth Rate (2013-2018)

5 North America Antiepileptic Drugs by Countries

5.1 North America Antiepileptic Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Antiepileptic Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Antiepileptic Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Antiepileptic Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Antiepileptic Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Antiepileptic Drugs Sales and Growth Rate (2013-2018)

6 Europe Antiepileptic Drugs by Countries

6.1 Europe Antiepileptic Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Antiepileptic Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Antiepileptic Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Antiepileptic Drugs Sales and Growth Rate (2013-2018)

6.3 UK Antiepileptic Drugs Sales and Growth Rate (2013-2018)

6.4 France Antiepileptic Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Antiepileptic Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Antiepileptic Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Antiepileptic Drugs by Countries

7.1 Asia-Pacific Antiepileptic Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Antiepileptic Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Antiepileptic Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Antiepileptic Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Antiepileptic Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Antiepileptic Drugs Sales and Growth Rate (2013-2018)

7.5 India Antiepileptic Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Antiepileptic Drugs Sales and Growth Rate (2013-2018)

8 South America Antiepileptic Drugs by Countries

8.1 South America Antiepileptic Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Antiepileptic Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Antiepileptic Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Antiepileptic Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Antiepileptic Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Antiepileptic Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Antiepileptic Drugs by Countries

9.1 Middle East and Africa Antiepileptic Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Antiepileptic Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Antiepileptic Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Antiepileptic Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Antiepileptic Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Antiepileptic Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Antiepileptic Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Antiepileptic Drugs Sales and Growth Rate (2013-2018)

10 Global Antiepileptic Drugs Market Segment by Type

10.1 Global Antiepileptic Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Antiepileptic Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Antiepileptic Drugs Revenue and Market Share by Type (2013-2018)

10.2 First generation Sales Growth and Price

10.2.1 Global First generation Sales Growth (2013-2018)

10.2.2 Global First generation Price (2013-2018)

10.3 Second generation Sales Growth and Price

10.3.1 Global Second generation Sales Growth (2013-2018)

10.3.2 Global Second generation Price (2013-2018)

11 Global Antiepileptic Drugs Market Segment by Application

11.1 Global Antiepileptic Drugs Sales Market Share by Application (2013-2018)

11.2 Hosptial Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

11.4 Research Sales Growth (2013-2018)

12 Antiepileptic Drugs Market Forecast (2018-2023)

12.1 Global Antiepileptic Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Antiepileptic Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Antiepileptic Drugs Market Forecast (2018-2023)

12.2.2 Europe Antiepileptic Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Antiepileptic Drugs Market Forecast (2018-2023)

12.2.4 South America Antiepileptic Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Antiepileptic Drugs Market Forecast (2018-2023)

12.3 Antiepileptic Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Antiepileptic Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Antiepileptic Drugs Market Share Forecast by Type (2018-2023)

12.4 Antiepileptic Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Antiepileptic Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Antiepileptic Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Antiepileptic Drugs Picture

Table Product Specifications of Antiepileptic Drugs

Figure Global Sales Market Share of Antiepileptic Drugs by Types in 2017

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery